Mediqstar

Gwangju, South Korea Founded: 2024 • Age: 2 yrs
Develops AI-based health tech for clinical research and tuberculosis kits in South Korea.
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products 2 Services tracked
Competitors 9 Brand Intelligence

About Mediqstar

Mediqstar is a company based in Gwangju (South Korea) founded in 2024. It operates as a B2B. Mediqstar offers products and services including TB Kit and CRO Services. Mediqstar operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others.

  • Headquarter Gwangju, South Korea
  • Sectors
    Technology
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Legal Name (주)메디큐스타
  • Jurisdiction Na, Maharashtra, India
Operational Areas
Technology → Artificial Intelligence & Machine Learning Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Genaxis

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Mediqstar

Mediqstar offers a comprehensive portfolio of products and services, including TB Kit and CRO Services.

Product name locked
Category locked
Primary

Diagnostic kit for tuberculosis detection using AI technology.

Product name locked
Category locked
Locked

Services for organizing and managing clinical trials and research.

Funding Insights of Mediqstar

Investors in Mediqstar

Mediqstar has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Genaxis and Pathfinder H.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
-
Locked Locked Locked
Premium access

Investor details for Mediqstar

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mediqstar

Investments
Premium access

Investment portfolio details for Mediqstar

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Mediqstar

Premium access

Detailed financials for Mediqstar

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mediqstar Comparisons

Mediqstar Primary company
Description
Develops AI-based health tech for clinical research and tube...
Location
Gwangju, South Korea
Founded Year
2024
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Mediqstar

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Mediqstar

Mediqstar operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, Predictive Oncology and BigHat, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
An agentic AI platform is developed for biomedical research insights.
Locked Locked Locked
AI-powered drug discovery platform for various diseases
Locked Locked Locked
AI-based technology is used for recombinant protein production in therapeutics.
Locked Locked Locked
AI-based platform for cancer diagnostics and precision medicine is utilized.
Locked Locked Locked
Antibody therapies are developed through machine learning and synthetic biology.
Locked Locked Locked
AI platform used for extracting antibody data from scientific papers.
Premium access

Detailed competitors of Mediqstar

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mediqstar

Premium access

Complete news archive for Mediqstar

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mediqstar

Mediqstar was founded in 2024 and raised its 1st funding round 1 year after it was founded.

Mediqstar is headquartered in Gwangju, South Korea.

Mediqstar is a technology company based in South Korea, specializing in AI applications for healthcare. They offer clinical research organization (CRO) services and develop tuberculosis (TB) kits for diagnostics. Operating from offices in Gwangju, Seoul, and Seongnam, the company focuses on innovative medical solutions through research and development. Their activities include providing tech-driven health products and services to support global health needs.

Mediqstar's top competitors include Owkin, Formation Bio and XtalPi.

Mediqstar offers TB Kit and CRO Services.

Mediqstar has 2 investors. Key investors include Genaxis, and Pathfinder H.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available